In this section:

24 July 2024

Unavailable Treatments - Curatoderm, Betnovate & Eumovate

Curatoderm Lotion & Ointment

In July 2024, Almirall informed us that Curatoderm Lotion was discontinued early in the year and is now out of stock.

Additionally, Curatoderm Ointment has been discontinued and stocks will be depleted by the end of 2024.

Almirall has stated this was a business decision, but could not provide the reason for discontinuation.

You may wish to contact Almirall customer care via phone on 0800 0087399, if you have any other queries.

Betnovate & Eumovate

In late 2023, we were made aware of a possible stock issue with Betnovate cream following reports from some of our members that the product had become difficult to obtain.

We contacted the manufacturer of Betnovate Cream, GSK, and they have confirmed that there has been a delay with manufacturing with both Betnovate and Eumovate.

The dates for these products to return to market are:

  • Betnovate ointment 0.1% 30g – available September 2024
  • Betnovate cream 0.1% 100g – available late July 2024
  • Betnovate cream 0.1% 30g - available August 2024
  • Betnovate RD ointment 0.025% 100g - available late August 2024
  • Eumovate ointment 0.05% 30g - available August 2024
  • For further information about these products please email GSK customer services at: customercontactuk@gsk.com

You can find more information about other currently unavailable treatments here.

Psoriderm Cream

After reports of stocks issue concerning Psoriderm Cream, we contacted Dermal Laboratories Limited.

Although Dermal Laboratories are progressing with reinstating its’ supply, due to an unforeseen delay Psoriderm Cream should be available again in late Summer 2024.

Please note that Psoriderm Scalp Lotion Shampoo remains available.

For further information about these products please contact Dermal Laboratories customer services on 01462 458 866 or email via info@dermal.co.uk.

Dermal Laboratories Limited expect to have further information on stock supply later this year.